NO | Bidhaa | CAS hapana | Maombi | Kiashiria muhimu cha ubora | ||||
Usafi | Isomer | Uchafu maalum | *Max1 | Unyevu | ||||
1 | FMOC-Cys (ACM) -oh | 86060-81-3 | Disulfide dhamana | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | FMOC-Cys (MMT) -oh | 177582-21-7 | Disulfide dhamana | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | FMOC-Cys (4-allylbutyrate) -oh | / | Disulfide dhamana | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | MPA (trt) -oh | 27144-18-9 | Mwisho wa mlolongo | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | FMOC-thr (TBU) -ol | 189337-28-8 | Octreotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | FMOC-D-Arg (PBF) -oh | 187618-60-6 | Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | FMOC-GLY-GLY-OH | 35665-38-4 | Bivalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | FMOC-GLY-GLY-GLY-OH | 170941-79-4 | Terlipressin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | FMOC-gly-gly-gly-gly-oh | / | Bivalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | FMOC-GLY-ASP (TBU) -oh | / | Bivalirudin | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | BOC-Cys (TRT) -oh | 21947-98-8 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | BOC-Arg (PBF) -oh | 200124-22-7 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | BOC-ALA-OH | 15761-38-3 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | BOC-D-PHE-OH | 18942-49-9 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | BOC-GLY-OH | 4530-20-5 | Mwisho wa mlolongo | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | Boc-lys (BOC) -oh.dcha | 15098-69-8 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | Boc-ser (tbu) -oh | 7738-22-9 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | Boc-thr (tbu) -oh | 13734-40-2 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | BOC-D-ALA-OH | 7764-95-6 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | BOC-MET-OH | 2488-15-5 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | Boc-tyr (tbu) -oh | 47375-34-8 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | BOC-D-Arg (PDF) -oh | 187618-60-6 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | BOC-ASP (OTBU) -oh.dcha | 1913/12/8 | Mwisho wa mlolongo | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | FMOC-HOMOARG (PBF) -oh | 1159680-21-3 | Eptifibatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | FMOC-ASP-OTBU | 129460-09-9 | Thymalfasin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | Fmoc-tyr (me) -oh | 77128-72-4 | Carbetocin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | Fmoc-orn (boc) -oh | 109425-55-0 | Atosiban Omnipressin Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | FMOC-D-Tyr (ET) -oh | 162502-65-0 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | FMOC-ASP (oall) -oh | 146982-24-3 | Melanotan | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | AC-NLE-OH | 15891-49-3 | Melanotan | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | FMOC-NLE-OH | 77284-32-3 | Melanotan Afamelanotide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | AC-Glu (OTBU) -oh | 84192-88-1 | Argireline Acetyl octapeptide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | AC-β-ALA-OH · DCHA | / | Acetyl tetrapeptide-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | FMOC-ß-ala-oh | 35737-10-1 | Acetyl tetrapeptide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | Fmoc-hyp (tbu) -oh | 122996-47-8 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | Fmoc-thi-oh | 130309-35-2 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | FMOC-D-TIC-OH | 130309-33-0 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | FMOC-OIC-OH | 130309-37-4 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | BOC-SAR-OH | 13734-36-6 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | FMOC-SAR-OH | 77128-70-2 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | FMOC-Tyr (SO3NA) -oh.H2O | 106864-37-3 | Sintialide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | FMOC-D-ASP (OTBU) -oh | 112883-39-3 | Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | Ac-ser (tbu) -oh | 77285-09-7 | Afamelanotide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | BOC-HOMOCYS (TRT) -oh | 201419-16-1 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | FMOC-HOMOCYS (TRT) -oh | 167015-23-8 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | FMOC-DAB-OH | 161420-87-7 | Sumu ya nyoka | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
*Max1 = usafi usiojulikana
Kiashiria kingine:
- Asidi ya asetiki: ≤0.02% (bidhaa zote)
- Ethyl acetate: ≤0.5% (bidhaa zote)
- Pombe: ≤0.5% (bidhaa zote)
-Max unnownow uchafu: FMOC-TRP (BOC) -oH (143824-78-6) ≤0.3%; Wengine ≤0.2%